Equifax Inc.

NYSE:EFX Lagerbericht

Marktkapitalisierung: US$20.9b

Equifax Zukünftiges Wachstum

Future Kriterienprüfungen 3/6

Equifax wird ein jährliches Gewinn- und Umsatzwachstum von 17.3% bzw. 8.4% prognostiziert. Der Gewinn pro Aktie wird voraussichtlich wachsen um 19.1% pro Jahr. Die Eigenkapitalrendite wird in 3 Jahren voraussichtlich 27% betragen.

Wichtige Informationen

17.3%

Wachstumsrate der Gewinne

19.14%

EPS-Wachstumsrate

Professional Services Gewinnwachstum15.5%
Wachstumsrate der Einnahmen8.4%
Zukünftige Eigenkapitalrendite27.00%
Analystenabdeckung

Good

Zuletzt aktualisiert11 May 2026

Jüngste Aktualisierungen zum künftigen Wachstum

Recent updates

Seeking Alpha • May 06

Equifax: Downgrading To Hold On Near-Term Uncertainty

Summary Equifax is downgraded to hold after a strong Q1 2026, with concerns about the sustainability of growth and margin leverage. Q1 revenue grew 14% y/y to $1.65B, driven by mortgage activity and robust Workforce Solutions (EWS) performance. Management did not raise 2026 guidance despite the beat, signaling caution on the earnings outlook and macro-driven mortgage recovery. EFX’s valuation is undemanding, but lack of margin expansion and mortgage dependency limit near-term rerating potential. Read the full article on Seeking Alpha
Analyse-Update • Apr 25

EFX: AI And Marketing Reset Will Support Long Term Earnings Power

Analysts trimmed the Equifax fair value estimate by about $7 to $229.19. Lower price targets from several firms, slightly higher discount rate assumptions, and a reduced revenue growth outlook were only partly balanced by a higher projected profit margin and a lower future P/E multiple.
Analyse-Update • Apr 11

EFX: AI Credit Tools And Marketing Reset Will Support Future Upside

Analysts have slightly reduced the average Equifax price target, with a modeled fair value moving from about $237.35 to $236.05. This change reflects updated views on discount rates, growth assumptions and recent target cuts across the Street.
Analyse-Update • Mar 26

EFX: AI Credit Tools And Marketing Shift Will Support Future Upside

Analysts have made only a small trim to the Equifax fair value estimate to $237.35, as recent price target cuts sit alongside views that the $1 VantageScore pricing move is mainly marketing and that sector wide expectations for revenue, EPS and free cash flow growth remain intact. Analyst Commentary Recent commentary around Equifax reflects a split between analysts who see the latest headlines as more noise than substance and those who are recalibrating their assumptions and price targets more cautiously.
Analyse-Update • Mar 11

EFX: AI Credit Tools And Buy Rating Will Shape Future Upside

Analysts have trimmed their average price target for Equifax by about $1 to $237.60, reflecting slightly higher discount rate assumptions, even as they factor in modestly stronger revenue growth, somewhat lower profit margins, and a higher future P/E after a recent wave of target reductions, alongside a fresh $250 Buy-level target from BofA. Analyst Commentary Recent Street research around Equifax reflects a mix of optimism on the long term earnings profile and caution around execution risks and valuation, especially after a cluster of price target cuts.
Analyse-Update • Feb 23

EFX: Credit Score Shift And AI Tools Will Shape Future Upside

Analysts have modestly trimmed their aggregate fair value estimate for Equifax to about $238.55 from $243.15, reflecting slightly higher discount rate and lower profit margin assumptions, while they continue to reference supportive long term growth expectations and a recent $250 price target from renewed coverage. Analyst Commentary Recent Street research on Equifax reflects a mix of cautious recalibration and ongoing confidence in the company’s long term earnings power.
Analyse-Update • Feb 08

EFX: Credit Score Shift And AI Risk Tools Will Support Future Upside

Analysts have trimmed their price targets on Equifax, reflected in a lower fair value estimate from $262.75 to $243.15, as they recalibrate P/E expectations and discount rates following a series of target cuts across the Street, while still modeling steady revenue growth and profit margins. Analyst Commentary Recent Street research on Equifax shows a clear reset in expectations, with a cluster of firms cutting price targets by amounts ranging from the mid teens to the low $40s.
Analyse-Update • Jan 24

EFX: Credit Score Competition And AI Fraud Tools Will Support Future Upside

Analysts have trimmed their price target on Equifax by about US$2 to US$262.75, citing updated assumptions around revenue growth, profit margins and future P/E that slightly adjust their overall valuation view. What's in the News The Federal Housing Finance Agency opened the door for VantageScore to compete with FICO in the home loan market, with Equifax, Experian and TransUnion owning VantageScore and potentially reshaping how mortgage credit scores are priced and sourced (Bloomberg).
Analyse-Update • Jan 08

EFX: High Entry Barriers Will Support Future Upside From Credit Score Competition

Analysts have trimmed their price targets on Equifax slightly, with one moving to a Hold at US$242 and another adjusting to US$271. These changes reflect updated views on growth, margins and future P/E assumptions following expected headwinds from FICO's Mortgage Direct License Program.
Analyse-Update • Dec 25

EFX: High Entry Barriers Will Support Future Outperformance Amid Mortgage Licensing Shift

Analysts have nudged their average price target for Equifax slightly lower, trimming fair value by approximately $0.50 to around $266.75 as they factor in modestly higher long term revenue growth and durable high quality assets, but also incremental earnings pressure and potential headwinds from FICO's new Mortgage Direct License Program. Analyst Commentary Analysts remain divided on Equifax, with views shaped by the competitive implications of FICO's Mortgage Direct License Program and the durability of Equifax's core data assets.
Analyse-Update • Dec 11

EFX: High Entry Barriers Will Sustain Resilience Amid FICO Mortgage License Headwinds

Analysts have nudged their average price target for Equifax slightly lower, trimming fair value by about $0.55 to roughly $267.25, as they factor in modestly higher long term headwinds from FICO's Mortgage Direct License Program and related credit bureau competition, despite still solid growth and margin assumptions. Analyst Commentary Street research reflects a mixed but generally constructive stance on Equifax, with views diverging around how disruptive FICO's Mortgage Direct License Program will ultimately be to the company's growth, margins, and valuation.
Analyse-Update • Nov 26

EFX: High Entry Barriers Will Sustain Core Resilience Amid Mortgage Score Disruption

Equifax's analyst price target has edged down by $0.50 to $267.80, as analysts cite near-term pressures on growth and profitability due to mortgage industry headwinds and changing competitive dynamics. Analyst Commentary Recent Street research highlights a mix of optimistic and cautious perspectives regarding Equifax's prospects, especially as the company navigates industry changes and competitive pressures.
Analyse-Update • Nov 09

EFX: Durable Competitive Advantages Will Offset Revenue Headwinds From Mortgage License Shift

Analysts have lowered their fair value estimate for Equifax to $268.30 from $272. They cite potential headwinds from industry changes and cautious revenue growth assumptions.
Analyse-Update • Oct 26

New Competitive Pressures And Regulatory Shifts Will Shape Market Leadership

Equifax's fair value estimate has been revised down from $277.70 to $272.00. Analysts cite ongoing revenue growth and margin pressures resulting from new industry headwinds and increased competition in the credit services market.
Analyse-Update • Oct 12

Government Verification And Cloud Migration Will Secure Future Advantage

Equifax's analyst price target has decreased from $280.50 to $277.70, as analysts note heightened industry headwinds and ongoing uncertainty following recent market and regulatory developments. Analyst Commentary Recent research reports highlight both opportunities and challenges for Equifax, as analysts adjust price targets and revisit expectations in light of evolving industry conditions and company-specific developments.
Analyseartikel • Jul 19

Returns On Capital Are Showing Encouraging Signs At Equifax (NYSE:EFX)

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Analyseartikel • Jun 22

Why Equifax Inc. (NYSE:EFX) Could Be Worth Watching

Let's talk about the popular Equifax Inc. ( NYSE:EFX ). The company's shares led the NYSE gainers with a relatively...
Analyseartikel • May 22

Equifax's (NYSE:EFX) Dividend Will Be Increased To $0.50

Equifax Inc. ( NYSE:EFX ) has announced that it will be increasing its dividend from last year's comparable payment on...
Seeking Alpha • Apr 24

Equifax: Fundamentals Are Better Than Expected, But Macro Risks Haven't Cleared

Summary I maintain a hold rating on Equifax despite a strong 1Q25 performance, as macro risks like high mortgage rates and poor hiring trends persist. Equifax's 1Q25 results exceeded expectations with $1.442 billion revenue and a 29.3% adj. EBITDA margin, driven by growth in all segments. New growth drivers, including the SSA deal and The Work Number platform, are showing strong potential, enhancing Equifax's long-term outlook. Despite positive fundamentals, near-term caution is warranted due to volatile mortgage volumes and hiring trends, along with macroeconomic uncertainties. Read the full article on Seeking Alpha
Seeking Alpha • Apr 14

Equifax Q1 Preview: Management's Thoughts On Outlook Should Be Interesting

Summary Analysts expect Equifax Inc.'s Q1 '25 results to show minimal growth, with EPS estimates at $1.41 adjusted and $1.00 GAAP on $1.42B revenue. Key concerns include weak U.S. mortgage and hiring markets, with 16 downward EPS revisions adding uncertainty to the upcoming results. Focus areas include U.S. mortgage inquiry declines, Workforce Solutions headwinds, and international performance, particularly in Brazil and Europe. Given the lackluster top-line growth and macroeconomic uncertainties, I don't recommend buying EFX stock before the earnings announcement. Read the full article on Seeking Alpha
Seeking Alpha • Feb 11

Equifax: Near-Term Weakness That May Lead To Guidance Revision (Rating Downgrade)

Summary I am downgrading Equifax stock to a hold rating due to weak FY25 guidance, soft mortgage inquiry outlook, and hiring market pressures. Despite solid 4Q24 results and medium-term growth potential, the near-term earnings outlook is poor with decelerating revenue and EPS growth. Elevated mortgage rates and declining hiring volumes are significant headwinds, limiting EFX's ability to sustain recent growth rates. The current 30x forward P/E valuation lacks margin of safety; I prefer waiting for a better entry point or clearer macro recovery signs. Read the full article on Seeking Alpha
Seeking Alpha • Jan 07

The 'New Equifax' Will Be More Profitable On New Cloud

Summary Equifax's transition to its own cloud and EFX.AI capabilities will drive revenue growth, margin expansion, and increased free cash flow, enhancing profitability. Lower CapEx and higher margins will boost earnings, with EPS expected to grow significantly, supporting a one-year price target of $306.75 and a Strong Buy rating. The new cloud platform will improve productivity, benefiting shareholders with increased returns. Despite recent stock volatility, the anticipated growth and financial benefits justify a 20.29% price increase, aligning with Wall Street analysts' positive outlook. Read the full article on Seeking Alpha

Gewinn- und Umsatzwachstumsprognosen

NYSE:EFX - Zukünftige Analystenschätzungen und Finanzdaten der Vergangenheit (USD Millions)
DatumUmsatzGewinneFreier CashflowBargeld aus operativen TätigkeitenDurchschn. Anz. Analysten
12/31/20288,1181,2221,5722,12214
12/31/20277,3901,0211,2751,76722
12/31/20266,7668441,0741,54122
3/31/20266,2816991,1391,634N/A
12/31/20256,0756601,1341,616N/A
9/30/20255,9436599991,470N/A
6/30/20255,8406409171,389N/A
3/31/20255,7346128091,296N/A
12/31/20245,6816048131,325N/A
9/30/20245,5885637841,322N/A
6/30/20245,4665836751,224N/A
3/31/20245,3535586441,219N/A
12/31/20235,2655455161,117N/A
9/30/20235,1375215081,120N/A
6/30/20235,0625244631,093N/A
3/31/20235,0615874801,107N/A
12/31/20225,122696133757N/A
9/30/20225,178710213817N/A
6/30/20225,156750312861N/A
3/31/20225,074764480993N/A
12/31/20214,9247448661,335N/A
9/30/20214,7896978021,247N/A
6/30/20214,6357207511,215N/A
3/31/20214,3836056131,059N/A
12/31/20204,128520525946N/A
9/30/20203,915470476880N/A
6/30/20203,722322-36348N/A
3/31/20203,619289-59314N/A
12/31/20193,508-384N/A314N/A
9/30/20193,437-382N/A248N/A
6/30/20193,396-425N/A565N/A
3/31/20193,393-347N/A584N/A
12/31/20183,412311N/A672N/A
9/30/20183,415447N/A715N/A
6/30/20183,416504N/A842N/A
3/31/20183,396525N/A832N/A
12/31/20173,362587N/A816N/A
9/30/20173,325538N/A888N/A
6/30/20173,294575N/A854N/A
3/31/20173,249540N/A819N/A
12/31/20163,145489N/A823N/A
9/30/20163,010478N/A750N/A
6/30/20162,873463N/A751N/A
3/31/20162,740443N/A747N/A
12/31/20152,664429N/A769N/A
9/30/20152,622415N/A740N/A
6/30/20152,568390N/A681N/A

Analystenprognosen zum zukünftigen Wachstum

Einkommen vs. Sparrate: EFXDas prognostizierte Gewinnwachstum (17.3% pro Jahr) liegt über der Sparquote (3.5%).

Ertrag vs. Markt: EFXDie Erträge des Unternehmens (17.3% pro Jahr) werden voraussichtlich schneller wachsen als der Markt US (16.7% pro Jahr).

Hohe Wachstumserträge: EFXDie Erträge des Unternehmens werden voraussichtlich steigen, jedoch nicht deutlich.

Einnahmen vs. Markt: EFXDie Einnahmen des Unternehmens (8.4% pro Jahr) werden voraussichtlich langsamer wachsen als der Markt US (11.6% pro Jahr).

Hohe Wachstumseinnahmen: EFXDie Einnahmen des Unternehmens (8.4% pro Jahr) werden voraussichtlich langsamer wachsen als 20% pro Jahr.

Wachstumsprognosen für den Gewinn je Aktie

Künftige Eigenkapitalrendite

Künftige Eigenkapitalrendite: EFXDie Eigenkapitalrendite des Unternehmens wird in 3 Jahren voraussichtlich hoch sein (27%)

Wachstumsunternehmen entdecken

7D

1Y

7D

1Y

7D

1Y

Unternehmensanalyse und Finanzdaten Status

DatenZuletzt aktualisiert (UTC-Zeit)
Unternehmensanalyse2026/05/11 02:57
Aktienkurs zum Tagesende2026/05/11 00:00
Gewinne2026/03/31
Jährliche Einnahmen2025/12/31

Datenquellen

Die in unserer Unternehmensanalyse verwendeten Daten stammen von S&P Global Market Intelligence LLC. Die folgenden Daten werden in unserem Analysemodell verwendet, um diesen Bericht zu erstellen. Die Daten sind normalisiert, was zu einer Verzögerung bei der Verfügbarkeit der Quelle führen kann.

PaketDatenZeitrahmenBeispiel US-Quelle *
Finanzdaten des Unternehmens10 Jahre
  • Gewinn- und Verlustrechnung
  • Kapitalflussrechnung
  • Bilanz
Konsensschätzungen der Analysten+3 Jahre
  • Finanzielle Vorausschau
  • Kursziele der Analysten
Marktpreise30 Jahre
  • Aktienkurse
  • Dividenden, Splits und Aktionen
Eigentümerschaft10 Jahre
  • Top-Aktionäre
  • Insiderhandel
Verwaltung10 Jahre
  • Das Führungsteam
  • Direktorium
Wichtige Entwicklungen10 Jahre
  • Ankündigungen des Unternehmens

* Beispiel für US-Wertpapiere, für nicht-US-amerikanische Wertpapiere werden gleichwertige regulatorische Formulare und Quellen verwendet.

Sofern nicht anders angegeben, beziehen sich alle Finanzdaten auf einen Jahreszeitraum, werden aber vierteljährlich aktualisiert. Dies wird als Trailing Twelve Month (TTM) oder Last Twelve Month (LTM) Daten bezeichnet. Erfahren Sie mehr.

Analysemodell und Schneeflocke

Einzelheiten zu dem Analysemodell, mit dem dieser Bericht erstellt wurde, finden Sie auf unserer Github-Seite. Außerdem bieten wir Leitfäden zur Verwendung unserer Berichte und Tutorials auf YouTube an.

Erfahren Sie mehr über das Weltklasse-Team, das das Simply Wall St-Analysemodell entworfen und entwickelt hat.

Metriken für Industrie und Sektor

Unsere Branchen- und Sektionskennzahlen werden alle 6 Stunden von Simply Wall St berechnet. Details zu unserem Verfahren finden Sie auf Github.

Analysten-Quellen

Equifax Inc. wird von 33 Analysten beobachtet. 22 dieser Analysten hat die Umsatz- oder Gewinnschätzungen übermittelt, die als Grundlage für unseren Bericht dienen. Die von den Analysten übermittelten Daten werden im Laufe des Tages aktualisiert.

AnalystEinrichtung
Jasper HellwegArgus Research Company
Jeffrey MeulerBaird
Manav PatnaikBarclays